Skip to main content
. 2002 Dec;54(6):604–609. doi: 10.1046/j.1365-2125.2002.01680.x

Table 2.

Pharmacokinetic parameters of quinine disposition, protein-binding of quinine and metabolism of quinine in control subjects and haemodialysis patients

Controls Haemodialysis Pvalue
Quinine disposition
Cmax (µg ml−1) 2.60 ± 0.99 4.56 ± 1.58 0.004
CLo (ml min−1 kg−1) 2.51 ± 1.59 1.41 ± 0.63 0.033
Vd area (l kg−1) 1.43 ± 0.78 0.95 ± 0.29 0.080
Kel (h−1) 0.106 ± 0.031 0.090 ± 0.023 0.221
t1/2 (h) 7.02 ± 1.72 8.26 ± 2.10 0.382
Protein-binding of quinine
Free fraction 0.063 ± 0.014 0.024 ± 0.015 0.001
(Bound/Free) AAG (l g−1) 26.0 ± 6.0 31.0 ± 13.4 0.191
(Bound/Free) albumin (l g−1) 0.4 ± 0.1 1.6 ± 0.4 0.001
Free CLo (ml min−1 kg−1) 41.1 ± 24.0 67.9 ± 32.0 0.033
Metabolism of quinine
Free fraction 0.063 ± .014 0.024 ± .015 0.001
AUC free quinine 2.11 ± 1.04 1.40 ± .55 0.080
AUC3-OH-Q 12.9 ± 4.3 45.1 ± 51.3 0.083
AUC10−11-Q 2.42 ± 0.89 4.46 ± 1.07 0.003
Ratio 3-OH-Q/free quinine 6.80 ± 2.12 46.30 ± 74.38 0.049
Ratio 10–11-Q/free quinine 1.36 ± .66 4.12 ± 3.04 0.002

Data are presented as mean ± s.d.